Logo image of DAN

DANA INC (DAN) Stock Fundamental Analysis

USA - NYSE:DAN - US2358252052 - Common Stock

20.88 USD
-0.16 (-0.76%)
Last: 9/15/2025, 3:58:10 PM
Fundamental Rating

2

Taking everything into account, DAN scores 2 out of 10 in our fundamental rating. DAN was compared to 80 industry peers in the Automobile Components industry. DAN may be in some trouble as it scores bad on both profitability and health. DAN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year DAN was profitable.
In the past year DAN had a positive cash flow from operations.
In multiple years DAN reported negative net income over the last 5 years.
Each year in the past 5 years DAN had a positive operating cash flow.
DAN Yearly Net Income VS EBIT VS OCF VS FCFDAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

The Return On Assets of DAN (-0.29%) is worse than 76.25% of its industry peers.
Looking at the Return On Equity, with a value of -1.99%, DAN is doing worse than 73.75% of the companies in the same industry.
With a Return On Invested Capital value of 2.47%, DAN is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for DAN is below the industry average of 8.51%.
Industry RankSector Rank
ROA -0.29%
ROE -1.99%
ROIC 2.47%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.11%
ROIC(5y)4.79%
DAN Yearly ROA, ROE, ROICDAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

Looking at the Operating Margin, with a value of 2.05%, DAN is doing worse than 78.75% of the companies in the same industry.
DAN's Operating Margin has declined in the last couple of years.
DAN has a worse Gross Margin (7.42%) than 91.25% of its industry peers.
In the last couple of years the Gross Margin of DAN has declined.
Industry RankSector Rank
OM 2.05%
PM (TTM) N/A
GM 7.42%
OM growth 3Y-6.44%
OM growth 5Y-14.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
DAN Yearly Profit, Operating, Gross MarginsDAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DAN is destroying value.
The number of shares outstanding for DAN has been increased compared to 1 year ago.
Compared to 5 years ago, DAN has more shares outstanding
DAN has a worse debt/assets ratio than last year.
DAN Yearly Shares OutstandingDAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
DAN Yearly Total Debt VS Total AssetsDAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

DAN has an Altman-Z score of 1.56. This is a bad value and indicates that DAN is not financially healthy and even has some risk of bankruptcy.
DAN has a worse Altman-Z score (1.56) than 81.25% of its industry peers.
DAN has a debt to FCF ratio of 107.59. This is a negative value and a sign of low solvency as DAN would need 107.59 years to pay back of all of its debts.
The Debt to FCF ratio of DAN (107.59) is worse than 78.75% of its industry peers.
DAN has a Debt/Equity ratio of 2.57. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.57, DAN is doing worse than 91.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF 107.59
Altman-Z 1.56
ROIC/WACC0.26
WACC9.43%
DAN Yearly LT Debt VS Equity VS FCFDAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

DAN has a Current Ratio of 1.36. This is a normal value and indicates that DAN is financially healthy and should not expect problems in meeting its short term obligations.
DAN has a Current ratio of 1.36. This is amonst the worse of the industry: DAN underperforms 87.50% of its industry peers.
DAN has a Quick Ratio of 1.00. This is a normal value and indicates that DAN is financially healthy and should not expect problems in meeting its short term obligations.
DAN has a Quick ratio of 1.00. This is amonst the worse of the industry: DAN underperforms 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
DAN Yearly Current Assets VS Current LiabilitesDAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.14% over the past year.
Measured over the past years, DAN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.71% on average per year.
DAN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.83%.
DAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.59% yearly.
EPS 1Y (TTM)7.14%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%63.19%
Revenue 1Y (TTM)-19.83%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-29.33%

3.2 Future

The Earnings Per Share is expected to grow by 24.63% on average over the next years. This is a very strong growth
DAN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.84% yearly.
EPS Next Y59.36%
EPS Next 2Y50.71%
EPS Next 3Y43.5%
EPS Next 5Y24.63%
Revenue Next Year-13.16%
Revenue Next 2Y-11.5%
Revenue Next 3Y-8.6%
Revenue Next 5Y-4.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DAN Yearly Revenue VS EstimatesDAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
DAN Yearly EPS VS EstimatesDAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.20 indicates a rather expensive valuation of DAN.
Based on the Price/Earnings ratio, DAN is valued a bit more expensive than 61.25% of the companies in the same industry.
DAN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 10.21 indicates a reasonable valuation of DAN.
DAN's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of DAN to the average of the S&P500 Index (22.73), we can say DAN is valued rather cheaply.
Industry RankSector Rank
PE 23.2
Fwd PE 10.21
DAN Price Earnings VS Forward Price EarningsDAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DAN's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DAN indicates a slightly more expensive valuation: DAN is more expensive than 76.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 94.43
EV/EBITDA 8.75
DAN Per share dataDAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DAN's earnings are expected to grow with 43.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y50.71%
EPS Next 3Y43.5%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.88%, DAN has a reasonable but not impressive dividend return.
DAN's Dividend Yield is comparable with the industry average which is at 3.89.
DAN's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.88%

5.2 History

The dividend of DAN decreases each year by -0.02%.
DAN has paid a dividend for at least 10 years, which is a reliable track record.
DAN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.02%
Div Incr Years0
Div Non Decr Years4
DAN Yearly Dividends per shareDAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

The earnings of DAN are negative and hence is the payout ratio. DAN will probably not be able to sustain this dividend level.
DP-241.67%
EPS Next 2Y50.71%
EPS Next 3Y43.5%
DAN Yearly Income VS Free CF VS DividendDAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

DANA INC

NYSE:DAN (9/15/2025, 3:58:10 PM)

20.88

-0.16 (-0.76%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners96.92%
Inst Owner Change-10.65%
Ins Owners0.45%
Ins Owner Change-0.02%
Market Cap2.74B
Analysts75.38
Price Target24.48 (17.24%)
Short Float %2.83%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 1.88%
Yearly Dividend0.4
Dividend Growth(5Y)-0.02%
DP-241.67%
Div Incr Years0
Div Non Decr Years4
Ex-Date08-08 2025-08-08 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-11.52%
Min Revenue beat(2)-24.38%
Max Revenue beat(2)1.34%
Revenue beat(4)1
Avg Revenue beat(4)-7.24%
Min Revenue beat(4)-24.38%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-4.59%
Revenue beat(12)5
Avg Revenue beat(12)-2.82%
Revenue beat(16)9
Avg Revenue beat(16)-0.67%
PT rev (1m)7.46%
PT rev (3m)23.08%
EPS NQ rev (1m)-34.52%
EPS NQ rev (3m)-22.38%
EPS NY rev (1m)1%
EPS NY rev (3m)8.12%
Revenue NQ rev (1m)-13.4%
Revenue NQ rev (3m)-12.23%
Revenue NY rev (1m)-7.68%
Revenue NY rev (3m)-7.76%
Valuation
Industry RankSector Rank
PE 23.2
Fwd PE 10.21
P/S 0.32
P/FCF 94.43
P/OCF 8.25
P/B 2.27
P/tB 2.43
EV/EBITDA 8.75
EPS(TTM)0.9
EY4.31%
EPS(NY)2.04
Fwd EY9.79%
FCF(TTM)0.22
FCFY1.06%
OCF(TTM)2.53
OCFY12.12%
SpS65.02
BVpS9.18
TBVpS8.58
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.29%
ROE -1.99%
ROCE 3.45%
ROIC 2.47%
ROICexc 2.7%
ROICexgc 2.75%
OM 2.05%
PM (TTM) N/A
GM 7.42%
FCFM 0.34%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.11%
ROIC(5y)4.79%
ROICexc(3y)5.65%
ROICexc(5y)5.25%
ROICexgc(3y)6.23%
ROICexgc(5y)5.9%
ROCE(3y)6.51%
ROCE(5y)6.09%
ROICexcg growth 3Y1.47%
ROICexcg growth 5Y-10.58%
ROICexc growth 3Y3.3%
ROICexc growth 5Y-9.33%
OM growth 3Y-6.44%
OM growth 5Y-14.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
F-Score2
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF 107.59
Debt/EBITDA 5.57
Cap/Depr 79.53%
Cap/Sales 3.55%
Interest Coverage 250
Cash Conversion 59.71%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1
Altman-Z 1.56
F-Score2
WACC9.43%
ROIC/WACC0.26
Cap/Depr(3y)107.96%
Cap/Depr(5y)101.61%
Cap/Sales(3y)4.26%
Cap/Sales(5y)4.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%63.19%
EPS Next Y59.36%
EPS Next 2Y50.71%
EPS Next 3Y43.5%
EPS Next 5Y24.63%
Revenue 1Y (TTM)-19.83%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-29.33%
Revenue Next Year-13.16%
Revenue Next 2Y-11.5%
Revenue Next 3Y-8.6%
Revenue Next 5Y-4.84%
EBIT growth 1Y-52.57%
EBIT growth 3Y-1.99%
EBIT growth 5Y-10.97%
EBIT Next Year118.96%
EBIT Next 3Y28.96%
EBIT Next 5Y16.84%
FCF growth 1Y-76.42%
FCF growth 3YN/A
FCF growth 5Y-19.8%
OCF growth 1Y-44.57%
OCF growth 3Y41.75%
OCF growth 5Y-6.71%